EFFECT OF ZOLEDRONIC ACID AND PAMIDRONATE ON SKELETAL-RELATED EVENTS AND MORTALITY IN WOMEN WITH BONE METASTASES FROM BREAST CANCER IN A MANAGED CARE PLAN: A RETROSPECTIVE DATABASE ANALYSIS

被引：0
|
作者：
Henk, H. J. [2 ]
Kaura, S. [1 ]
机构：
[1] Novartis Pharmaceut, Florham Pk, NJ USA
[2] i3 Innovus, Eden Prairie, MN USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)71910-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A253 / A253
页数：1
相关论文
共 50 条
  • [31] A COMPARISON OF THE COST-EFFECTIVENESS OF ZOLEDRONIC ACID FOR PREVENTING SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES FROM PROSTATE CANCER IN 4 EUROPEAN COUNTRIES
    Botteman, M.
    Carter, J.
    Kaura, S.
    VALUE IN HEALTH, 2010, 13 (07) : A264 - A264
  • [32] The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer
    Delea, T
    Langer, C
    McKiernan, J
    Liss, M
    Edelsberg, J
    Brandman, J
    Sung, J
    Raut, M
    Oster, G
    ONCOLOGY, 2004, 67 (5-6) : 390 - 396
  • [33] COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES
    Bell, M. J.
    Miller, J. D.
    Namjoshi, M.
    Russell, M. W.
    VALUE IN HEALTH, 2011, 14 (03) : A159 - A159
  • [34] Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment
    Park, Se Young
    Kim, Hyun-Jeong
    Kim, Ki Rim
    Lee, Sun Kyoung
    Lee, Chang Ki
    Park, Kwang-Kyun
    Chung, Won-Yoon
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2014, 275 (02) : 152 - 162
  • [35] Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art
    Clemons, M.
    Gelmon, K. A.
    Pritchard, K. I.
    Paterson, A. H. G.
    CURRENT ONCOLOGY, 2012, 19 (05) : 259 - 268
  • [36] A retrospective database analysis to assess the impact of zoledronic acid (ZOL) on skeletal-related events (SREs) in solid tumor cancer and multiple myeloma (MM) patients (pts)
    Thayer, S.
    Cooke, J.
    Kaura, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival
    van der Pol, Christian B.
    Schweitzer, Mark E.
    Di Primio, Gina
    Sampaio, Marcos L.
    Kielar, Ania
    Clemons, Mark
    Jaberi, Arash
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 146 (03) : 583 - 589
  • [38] Survival-adjusted cumulative event analysis of skeletal-related events in patients with cancer metastatic to bone in trials of zoledronic acid
    Major, PP
    Cook, RJ
    Chen, BL
    Zheng, M
    BONE, 2004, 34 : S88 - S88
  • [39] The cost of treating skeletal-related events in patients with bone metastases secondary to breast, lung, or prostate cancer
    Barber, B.
    Oglesby, A.
    Lage, M. J.
    Harrison, D. J.
    Jun, S.
    VALUE IN HEALTH, 2008, 11 (03) : A69 - A69
  • [40] Skeletal-related events (SRE) prevented in breast cancer patients with bone metastases in the United States (US)
    Arellano, J.
    Chen, K.
    Halperin, M.
    Danese, M.
    CANCER RESEARCH, 2013, 73
12345